3701 - 3710 of 6431 Results
Title
Year
-
OPENTitle: Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primatesJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 6Issue #: 20Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/sciadv.aaz9165Best OA location URL: https://advances.sciencemag.org/content/advances/6/20/eaaz9165.full.pdfCitation Count: 53
-
OPENTitle: A new biology of cell penetrating peptidesJournal Name: Peptide SciencePublisher: WileyVol: 113Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/pep2.24154Best OA location URL: http://hdl.handle.net/2436/623251Citation Count: 7
-
OPENTitle: Endoplasmic Reticulum Membrane Contact Sites, Lipid Transport, and NeurodegenerationJournal Name: Cold Spring Harbor Perspectives in BiologyPublisher: Cold Spring Harbor LaboratoryVol: 15Issue #: 4Start Page: a041257End Page: a041257Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1101/cshperspect.a041257Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10071438/pdf/cshperspect-ERT-a041257.pdfCitation Count: 35
-
OPENTitle: UCP2 mediates ghrelin’s action on NPY/AgRP neurons by lowering free radicalsJournal Name: NaturePublisher: Springer Science and Business Media LLCVol: 454Issue #: 7206Start Page: 846End Page: 851Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nature07181Citation Count: 685
-
OPENTitle: Pitx3 is required for development of substantia nigra dopaminergic neuronsJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 100Issue #: 7Start Page: 4245End Page: 4250Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.0230529100Best OA location URL: http://doi.org/10.1073/pnas.0230529100Citation Count: 382
-
OPENTitle: Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson’s disease modelsJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 3Issue #: 3-4Start Page: 194End Page: 208Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1242/dmm.004267Best OA location URL: http://doi.org/10.1242/dmm.004267Citation Count: 178
-
OPENTitle: Decrease in Skin Prion-Seeding Activity of Prion-Infected Mice Treated with a Compound Against Human and Animal Prions: a First Possible Biomarker for Prion TherapeuticsJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 58Issue #: 9Start Page: 4280End Page: 4292Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12035-021-02418-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s12035-021-02418-6.pdfCitation Count: 15
- The AKT modulator A-443654 reduces α-synuclein expression and normalizes ER stress and autophagy2021OPENTitle: The AKT modulator A-443654 reduces α-synuclein expression and normalizes ER stress and autophagyJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 297Issue #: 4Start Page: 101191End Page: 101191Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jbc.2021.101191Best OA location URL: http://www.jbc.org/article/S0021925821009935/pdfCitation Count: 13
-
OPENTitle: Oromandibular Dystonia: A Clinical Examination of 2,020 CasesJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.700714Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.700714/pdfCitation Count: 32
-
OPENTitle: Characterizing white matter alterations subject to clinical laterality in drug‐naïve de novo Parkinson's diseaseJournal Name: Human Brain MappingPublisher: WileyVol: 42Issue #: 14Start Page: 4465End Page: 4477Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/hbm.25558Best OA location URL: https://doi.org/10.1002/hbm.25558Citation Count: 20